Alltracel continues steady growth

FLEDGLING pharmaceutical company Alltracel continued to make steady progress yesterday by announcing full-year revenues of €4.6 million, up from €1m in 2003.

But pre-tax losses for the year to December doubled to €5.4m as the Sallynoggin-based company’s bills for sales, distribution and marketing soared.

Chief executive Tony Richardson, who took over from company founder Gerry Brandon during the year, said revenue growth was “strong and accelerating” and was down to a successful business model that focused on the consumer wound care market.